Green Tea Extract (EGCG)vsRetinyl Palmitate

EGCG scavenges ROS (superoxide, hydroxyl radical, peroxynitrite) and chelates iron/copper that catalyze Fenton reactions. Inhibits MMP-2 (gelatinase A) and MMP-9 (gelatinase B) that degrade collagen types I, III, IV and elastin in photoaged skin — these enzymes are UV-upregulated via AP-1 and NF-kappa B. Reduces sebum by inhibiting 5-alpha reductase type 1 (testosterone to DHT conversion in sebaceous glands). Anti-inflammatory: NF-kappa B inhibition (I-kappa B degradation prevention), COX-2 suppression, TNF-alpha/IL-1beta reduction. Promotes keratinocyte differentiation via involucrin and filaggrin upregulation. Catechol structure enables dual antioxidant and metal-chelating activity. Topical EGCG reduces UV-induced erythema and prevents collagen degradation when used before sun exposure.

Retinyl palmitate is cleaved by cutaneous esterases (including retinyl ester hydrolase) to release retinol, which then undergoes oxidation by retinol dehydrogenase to retinaldehyde, followed by RALDH conversion to retinoic acid. The three-step enzymatic cascade means very little active retinoic acid reaches nuclear RAR receptors at any given time, explaining the low potency and minimal retinization. The palmitate ester bond provides exceptional stability — resistant to UV-induced isomerization and oxidative degradation that affects retinol. This slow-release profile makes it suitable for sensitive skin and daytime use. The limited retinoic acid flux still provides mild stimulation of collagen type I synthesis and epidermal turnover, though clinical effects are subtle compared to stronger retinoids.